Octave Announces Publication of Analytical Validation Study Results in Nature Communications More

News & Blog

Catch the latest

Recent Announcements & Press

Octave Bioscience Accelerates Leadership in Precision Care for Neurodegenerative Diseases with Addition of World-Class Commercial Executives – Businesswire

Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis – Annals of Clinical and Translational Neurology

Taking Aim at Multiple Sclerosis – Journal of Clinical Pathways

Octave Note

Leveraging Biology for Better Informed Treatment Decisions

Precision Medicine: Biomarkers as an Objective Measure

Octave at ECTRIMS: An Overview of Scientific Research Presented on Our MS Precision Care Solution

Media Library

living well

Being Diagnosed with Multiple Sclerosis

living well

Earliest Stages of Multiple Sclerosis

living well

Is My MS Controlled?